what medications are glp 1 New GLP-1 Guidelines for Type 2 Diabetes in 2025 What to Make of the
Description
Orforglipron: Phase 3 trial results are expected in 2025
Lefkowitz, R
JASCAYD is a first-in-class PDE4B inhibitor for IPF
There are differences in the efficacy and mechanisms of different GLP-1RAs in the treatment of DPN
